West Declares Quarterly Dividend
West Pharmaceutical Services (NYSE: WST) announced that its Board of Directors declared a regular quarterly dividend of $0.22 per share on its common stock on July 21, 2026.
Rhea-AI Summary
West Pharmaceutical Services (NYSE: WST) announced that its Board of Directors declared a regular quarterly dividend of $0.22 per share on its common stock on July 21, 2026. The dividend will be paid on August 5, 2026 to shareholders of record as of July 29, 2026.
Positive
- Quarterly dividend declared at $0.22 per share on common stock
- Payment date set for August 5, 2026, with record date July 29, 2026
Negative
- None.
Details
News Market Reaction – WST
In the Jul 22 session, WST declined 0.23%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
About West
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life saving and life enhancing medicines for patients. With over 10,000 team members across 50 sites including 26 manufacturing facilities worldwide, West helps support our customers by delivering over 41 billion components and devices each year.
Headquartered in Exton, Pennsylvania, West in its fiscal year 2025 generated
All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted.
View original content to download multimedia:https://www.prnewswire.com/news-releases/west-declares-quarterly-dividend-302831155.html
SOURCE West Pharmaceutical Services, Inc.